Prediction Markets’ Risks Warrant Biopharma Compliance Measures

Bloomberg Law published an article coauthored by partner Jerrob Duffy and associate Daniel Liberman on the growing risks prediction markets pose to biopharma and other companies with valuable proprietary information. The article discusses relevant enforcement actions and measures companies can consider to minimize related financial, reputational and litigation risks.

Click here to read the article.

This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm's data policy page for further information.